Gala Therapeutics Overview
- Year Founded
-
2015
- Status
-
Acquired/Merged
- Employees
-
24
- Latest Deal Type
-
M&A
Gala Therapeutics General Information
Description
Developer of disease-modifying therapies designed to improve survival, quality of life and outcomes for patients with lung cancer, COPD, asthma, and other pulmonary diseases. The company's platform offers a single-use catheter and electrosurgical generator to deliver non-thermal energy to the airways to reduce mucus-producing cells in patients, enabling physicians to treat their patients better, resulting in a better medical outcome.
Contact Information
Website
www.galatherapeutics.comCorporate Office
- 1531 Industrial Road
- San Carlos, CA 94070
- United States
Corporate Office
- 1531 Industrial Road
- San Carlos, CA 94070
- United States
Gala Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 15-Sep-2022 | Completed | Generating Revenue | |||
| 2. Later Stage VC | 22-Mar-2022 | Completed | Generating Revenue | |||
| 1. Early Stage VC (Series A) | 18-Nov-2019 | $42.5M | $42.5M | Completed | Generating Revenue |
Gala Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
Gala Therapeutics Comparisons
Industry
Financing
Details
Gala Therapeutics Competitors (3)
One of Gala Therapeutics’s 3 competitors is RejuvenAir, a Venture Capital-Backed company based in Lexington, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| RejuvenAir | Venture Capital-Backed | Lexington, MA | ||||
| Nuvaira | Venture Capital-Backed | Maple Grove, MN | ||||
| Pulmonx | Formerly VC-backed | Redwood City, CA |
Gala Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Gala Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Gala Therapeutics Former Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Apple Tree Partners (ATP) | Venture Capital | Minority |
Gala Therapeutics FAQs
-
When was Gala Therapeutics founded?
Gala Therapeutics was founded in 2015.
-
Where is Gala Therapeutics headquartered?
Gala Therapeutics is headquartered in San Carlos, CA.
-
What is the size of Gala Therapeutics?
Gala Therapeutics has 24 total employees.
-
What industry is Gala Therapeutics in?
Gala Therapeutics’s primary industry is Therapeutic Devices.
-
Is Gala Therapeutics a private or public company?
Gala Therapeutics is a Private company.
-
What is Gala Therapeutics’s current revenue?
The current revenue for Gala Therapeutics is .
-
How much funding has Gala Therapeutics raised over time?
Gala Therapeutics has raised $48.5M.
-
Who are Gala Therapeutics’s investors?
Apple Tree Partners (ATP) has invested in Gala Therapeutics.
-
Who are Gala Therapeutics’s competitors?
RejuvenAir, Nuvaira, and Pulmonx are competitors of Gala Therapeutics.
-
When was Gala Therapeutics acquired?
Gala Therapeutics was acquired on 15-Sep-2022.
-
Who acquired Gala Therapeutics?
Gala Therapeutics was acquired by Galvanize Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
